### §353a–1. Enhanced communication
#### (a) Submissions from State boards of pharmacy
* In a manner specified by the Secretary of Health and Human Services (referred to in this section as the "Secretary"), the Secretary shall receive submissions from State boards of pharmacy—

  * (1) describing actions taken against compounding pharmacies, as described in subsection (b); or

  * (2) expressing concerns that a compounding pharmacy may be acting contrary to section 353a of this title.

#### (b) Content of submissions from State boards of pharmacy
* An action referred to in subsection (a)(1) is, with respect to a pharmacy that compounds drugs, any of the following:

  * (1) The issuance of a warning letter, or the imposition of sanctions or penalties, by a State for violations of a State's pharmacy regulations pertaining to compounding.

  * (2) The suspension or revocation of a State-issued pharmacy license or registration for violations of a State's pharmacy regulations pertaining to compounding.

  * (3) The recall of a compounded drug due to concerns relating to the quality or purity of such drug.

#### (c) Consultation
* The Secretary shall implement subsection (a) in consultation with the National Association of Boards of Pharmacy.

#### (d) Notifying State boards of pharmacy
* The Secretary shall immediately notify State boards of pharmacy when—

  * (1) the Secretary receives a submission under subsection (a)(1); or

  * (2) the Secretary makes a determination that a pharmacy is acting contrary to section 353a of this title.